Paul B. Manning - 27 Jul 2021 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, Attorney-in-Fact
Issuer symbol
CADL
Transactions as of
27 Jul 2021
Transactions value $
$410,778
Form type
4
Filing time
29 Jul 2021, 21:02:52 UTC
Previous filing
26 Jul 2021
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $265K +36K $7.36* 36K 27 Jul 2021 Direct F1, F2
transaction CADL Common Stock Purchase $146K +20K +55.56% $7.30* 56K 29 Jul 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.31 to $7.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F2 Shares held jointly with spouse.
F3 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.855 to $7.80. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Remarks:

Exhibit 24 - Power of Attorney